Results 161 to 170 of about 23,476 (212)

[Impact of an integrated and centralized drug policy: the case of the province of Buenos Aires, ArgentinaImpacto de uma política de medicamentos integrada e centralizada: o caso da província de Buenos Aires, Argentina]. [PDF]

Rev Panam Salud Publica
Marín GH, Capallo AP, Cocco MH, Álvarez JI, Leone F, Pesci SA, Konfino J, Kreplak N.   +7 more
europepmc   +1 more source

Estrategia de seguridad y defensa de los Estados Unidos de América

, 2019
Yesid Eduardo Ramírez Pedraza, Stefany García Sintura   +1 more
openaire   +2 more sources

Expert consensus on vaccination as a primary prevention strategy for women of reproductive age, pregnant, or adulthood [PDF]

Rev Colomb Obstet Ginecol
Miranda Quintero J, Celis-Amórtegui M, Arturo Rojas MC, Mendoza Rosado L, Grillo-Ardila CF, Grillo-Ardila EK, Ramírez-Mosquera JJ, Lovera LA, Ramírez-Mosquera MJ.   +8 more
europepmc   +1 more source

Policy implications of WHO's Global traditional medicine strategy 2025-2034. [PDF]

Bull World Health Organ
Wong YMA, Ahn S, Bana A, Dua PK, Eggers R, Kuruvilla S, Li Y, Liu Q, Shen Y, Kim S.   +9 more
europepmc   +1 more source

[Distribution of the COVID-19 vaccine: experience in EcuadorOperacionalização da vacinação contra a COVID‑19: experiência no Equador]. [PDF]

Rev Panam Salud Publica
Ruales J, Garzón X, Aldaz C, Vásconez N, Jácome F, Cevallos J, Pinos J, Pérez-Tasigchana F, Díaz A, Whittembury A.   +9 more
europepmc   +1 more source

[Strategic independence: a value model for improving access to plasma-derived medicines in Latin AmericaIndependência estratégica: modelo de valor para melhorar o acesso a hemoderivados na América Latina]. [PDF]

Rev Panam Salud Publica
Vahos Zambrano J, Vaca González C, Cortés AY, Bernal DR, Parra Galvis R, von Bonsdorff L.   +5 more
europepmc   +1 more source

[Telemedicine and access to healthcare: Advantages and disadvantages in the digital era]. [PDF]

Aten Primaria
Saperas Pérez C, Sequeira Aymar E, Barlam Torres N.   +2 more
europepmc   +1 more source

Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market. [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Caffaratti M, Cañás M, Domosbian DE, Giraudo E, González AM, Lorenzo A, Núñez Montoya S, Rocha MT, Traverso ML, Uema S.   +9 more
europepmc   +1 more source